Cargando…
Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors
BACKGROUND: Expression of c-myc proto-oncogene is inappropriate in a wide range of human tumors, and is a downstream target of Ras/Raf/ERK pathway, which promotes c-Myc stability by enhancing c-Myc expression and activity. The aim of this study was to investigate whether the oncogenic phenotype in t...
Autores principales: | Marampon, Francesco, Ciccarelli, Carmela, Zani, Bianca M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1560159/ https://www.ncbi.nlm.nih.gov/pubmed/16899113 http://dx.doi.org/10.1186/1476-4598-5-31 |
Ejemplares similares
-
Biological Rationale for Targeting MEK/ERK Pathways in Anti-Cancer Therapy and to Potentiate Tumour Responses to Radiation
por: Marampon, Francesco, et al.
Publicado: (2019) -
p21(WAF1 )expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells
por: Ciccarelli, Carmela, et al.
Publicado: (2005) -
Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population
por: Ciccarelli, Carmela, et al.
Publicado: (2016) -
Anti-oncogenic and pro-myogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcoma
por: Di Rocco, Agnese, et al.
Publicado: (2022) -
IGHG1 Regulates Prostate Cancer Growth via the MEK/ERK/c-Myc Pathway
por: Chu, Jing, et al.
Publicado: (2019)